110 related articles for article (PubMed ID: 10916040)
1. [Contribution and limitations of evaluation scales in Parkinson's disease].
Tison F
Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():76-80. PubMed ID: 10916040
[TBL] [Abstract][Full Text] [Related]
2. [Rating scales for Parkinson's disease: when and how to use them].
Bonnet AM
Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():70-5. PubMed ID: 10916039
[TBL] [Abstract][Full Text] [Related]
3. [Rating scales and questionnaires in Parkinson's disease].
Mauduit N; Schück S; Allain H; Chaperon J
Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():63-9. PubMed ID: 10916038
[TBL] [Abstract][Full Text] [Related]
4. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of idiopathic Parkinson's disease in physical medicine and rehabilitation].
Pelissier J; Benaim C; Bonin-Koang KY; Castelnovo G; Perennou D
Ann Readapt Med Phys; 2005 Jul; 48(6):341-5. PubMed ID: 15932779
[TBL] [Abstract][Full Text] [Related]
6. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
Kulisevsky J; Pagonabarraga J
Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
[TBL] [Abstract][Full Text] [Related]
9. [The usefulness of timed motor tests in assessing Parkinson's disease].
García-Ruiz PJ; Sánchez-Bernardos V; Cabo-López I
Rev Neurol; 2009 Jun 16-30; 48(12):617-9. PubMed ID: 19507119
[TBL] [Abstract][Full Text] [Related]
10. Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?
Martínez-Martín P; Benito-León J; Alonso F; Catalán MJ; Pondal M; Tobías A; Zamarbide I
Mov Disord; 2003 Sep; 18(9):985-92. PubMed ID: 14502665
[TBL] [Abstract][Full Text] [Related]
11. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.
Forjaz MJ; Martinez-Martin P
Mov Disord; 2006 Nov; 21(11):1892-8. PubMed ID: 16958134
[TBL] [Abstract][Full Text] [Related]
12. Impact of the motor complications of Parkinson's disease on the quality of life.
Chapuis S; Ouchchane L; Metz O; Gerbaud L; Durif F
Mov Disord; 2005 Feb; 20(2):224-30. PubMed ID: 15384126
[TBL] [Abstract][Full Text] [Related]
13. Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments.
Metman LV; Myre B; Verwey N; Hassin-Baer S; Arzbaecher J; Sierens D; Bakay R
Mov Disord; 2004 Sep; 19(9):1079-1084. PubMed ID: 15372601
[TBL] [Abstract][Full Text] [Related]
14. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE; Weintraub D; Sampaio C; Poewe W; Rascol O; Stebbins GT; Goetz CG
Mov Disord; 2008 Oct; 23(14):2004-14. PubMed ID: 18709683
[TBL] [Abstract][Full Text] [Related]
15. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
Grosset KA; Grosset DG
Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
[TBL] [Abstract][Full Text] [Related]
16. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD).
Martínez-Martín P; Forjaz MJ; Cubo E; Frades B; de Pedro Cuesta J;
Mov Disord; 2006 Feb; 21(2):208-14. PubMed ID: 16161158
[TBL] [Abstract][Full Text] [Related]
17. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
[TBL] [Abstract][Full Text] [Related]
18. [Neuropsychiatric problems in patients with Parkinson's disease].
Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
[TBL] [Abstract][Full Text] [Related]
19. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
20. Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfallers based on standardized clinical measures.
Landers MR; Backlund A; Davenport J; Fortune J; Schuerman S; Altenburger P
J Neurol Phys Ther; 2008 Jun; 32(2):56-61. PubMed ID: 18645292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
